Stocks
Sarepta Therapeutics (SRPT) EV/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -19.4 | -23.5 | -15.4 | -23.2 | -32.2 | -99.3 | ||
| Changes by years, y/y, % | +3% | +21% | -34% | +51% | +39% | +11.3% | |||
Sarepta Therapeutics. EV/EBITDA
Sarepta Therapeutics. EV/EBITDA, changes, %
Sarepta Therapeutics (SRPT) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EV/EBITDA | ? | -23.0 | -24.0 | -37.4 | -38.9 | -165.0 | -99.3 | |
| Changes by years, y/y, % | -3% | +65% | +99% | +67% | +619% | |||
| Changes by quarters, q/q, % | -1% | +5% | +56% | +4% | +324% | |||
